Elizabeth M. Anderson, a director at Insmed Inc. (NASDAQ: INSM), made two open market sales of INSM stock totaling nearly $3 million over the last year, with her most recent sale on November 24, 2025. No open market purchases were recorded. Her sales rank 2,738th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | G | Common Stock | 15000 | $0.00 | 50,205.0000 | 193,319,805 | 23.00% | 0.01% |
| March 4, 2026 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | G | Common Stock | 15000 | $0.00 | 50,205.0000 | 193,319,805 | 42.61% | 0.01% |
| Nov. 24, 2025 | INSMED Inc | $INSM | ANDERSON ELIZABETH M | Director | S | Common Stock | 5000 | $204.58 | 58,729.0000 | 213,273,469 | 7.85% | 0.00% |
| Nov. 14, 2025 | INSMED Inc | $INSM | ANDERSON ELIZABETH M | Director | S | Common Stock | 10000 | $195.87 | 63,729.0000 | 213,273,469 | 13.56% | 0.00% |
| June 26, 2025 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Common Stock | 3142 | $0.00 | 50,205.0000 | 185,913,326 | 6.68% | 0.00% |
| June 26, 2025 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Stock Option (Right to Buy) | 11574 | $0.00 | 11,574.0000 | 185,913,326 | 9999.99% | 0.01% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | ANDERSON ELIZABETH M | Director | A | Common Stock | 6650 | $0.00 | 34,450.0000 | 196,708,000 | 23.92% | 0.00% |
| May 15, 2025 | INSMED Inc | $INSM | ANDERSON ELIZABETH M | Director | A | Common Stock | 5058 | $0.00 | 73,729.0000 | 180,999,350 | 7.37% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Stock Option (Right to Buy) | 15955 | $0.00 | 15,955.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Common Stock | 4248 | $0.00 | 47,063.0000 | 0 | 9.92% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Stock Option (Right to Buy) | 16700 | $0.00 | 16,700.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Common Stock | 4800 | $0.00 | 47,615.0000 | 0 | 11.21% | 0.00% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | ANDERSON ELIZABETH M | Director | A | Common Stock | 4720 | $0.00 | 27,800.0000 | 191,595,000 | 20.45% | 0.00% |
| May 13, 2024 | INSMED Inc | $INSM | ANDERSON ELIZABETH M | Director | A | Common Stock | 13162 | $0.00 | 68,671.0000 | 0 | 23.71% | 0.00% |
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Common Stock | 5200 | $0.00 | 42,815.0000 | 0 | 13.82% | 0.00% |
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | ANDERSON ELIZABETH M | Not found | A | Stock Option (Right to Buy) | 18400 | $0.00 | 18,400.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | ANDERSON ELIZABETH M | Director | A | Common Stock | 4190 | $0.00 | 23,080.0000 | 188,963,000 | 22.18% | 0.00% |